Antibody-Independent Isolation of Circulating Tumor Cells by Continuous-Flow Dielectrophoresis

Access full-text files




Shim, Sangjo
Stemke-Hale, Katherine
Tsimberidou, Apostolia M.
Noshari, Jamileh
Anderson, Thomas E.
Gascoyne, Peter R. C.

Journal Title

Journal ISSN

Volume Title



Circulating tumor cells (CTCs) are prognostic markers for the recurrence of cancer and may carry molecular information relevant to cancer diagnosis. Dielectrophoresis (DEP) has been proposed as a molecular marker-independent approach for isolating CTCs from blood and has been shown to be broadly applicable to different types of cancers. However, existing batch-mode microfluidic DEP methods have been unable to process 10 ml clinical blood specimens rapidly enough. To achieve the required processing rates of 106 nucleated cells/min, we describe a continuous flow microfluidic processing chamber into which the peripheral blood mononuclear cell fraction of a clinical specimen is slowly injected, deionized by diffusion, and then subjected to a balance of DEP, sedimentation and hydrodynamic lift forces. These forces cause tumor cells to be transported close to the floor of the chamber, while blood cells are carried about three cell diameters above them. The tumor cells are isolated by skimming them from the bottom of the chamber while the blood cells flow to waste. The principles, design, and modeling of the continuous-flow system are presented. To illustrate operation of the technology, we demonstrate the isolation of circulating colon tumor cells from clinical specimens and verify the tumor origin of these cells by molecular analysis. (C) 2013 American Institute of Physics. []


LCSH Subject Headings


Shim, Sangjo, Katherine Stemke-Hale, Apostolia M. Tsimberidou, Jamileh Noshari, Thomas E. Anderson, and Peter RC Gascoyne. "Antibody-independent isolation of circulating tumor cells by continuous-flow dielectrophoresis." Biomicrofluidics, Vol. 7, No. 1 (Jan., 2013): 011807.